Global Sorafenib Sales Market Report Forecast 2017 to 2022

November 2017 | 105 pages | ID: G1B1874A720EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals

Product Segment Analysis:
Type 1
Type 2
Type 3

Application Segment Analysis:
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 SORAFENIB MARKET OVERVIEW

1.1 Product Overview and Scope of Sorafenib
1.2 Classification of Sorafenib
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Sorafenib
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Sorafenib Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Sorafenib (2012-2022)
  1.5.1 Global Sorafenib Sales and Growth Rate (2012-2022)
  1.5.2 Global Sorafenib Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON SORAFENIB INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 SORAFENIB MANUFACTURING COST ANALYSIS

3.1 Sorafenib Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Sorafenib

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Sorafenib Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Sorafenib Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL SORAFENIB COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Sorafenib Market Competition by Manufacturers
  5.1.1 Global Sorafenib Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Sorafenib Revenue and Share by Manufacturers (2012-2017)
5.2 Global Sorafenib (Volume and Value) by Type
  5.5.1 Global Sorafenib Sales and Market Share by Type (2012-2017)
  5.5.2 Global Sorafenib Revenue and Market Share by Type (2012-2017)
5.3 Global Sorafenib (Volume and Value) by Regions
  5.3.1 Global Sorafenib Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Sorafenib Revenue and Market Share by Regions (2012-2017)
5.4 Global Sorafenib (Volume) by Application

6 UNITED STATES SORAFENIB (VOLUME, VALUE AND SALES PRICE)

6.1 United States Sorafenib Sales and Value (2012-2017)
  6.1.1 United States Sorafenib Sales and Growth Rate (2012-2017)
  6.1.2 United States Sorafenib Revenue and Growth Rate (2012-2017)
  6.1.3 United States Sorafenib Sales Price Trend (2012-2017)
6.2 United States Sorafenib Sales and Market Share by Manufacturers
6.3 United States Sorafenib Sales and Market Share by Type
6.4 United States Sorafenib Sales and Market Share by Application

7 CHINA SORAFENIB (VOLUME, VALUE AND SALES PRICE)

7.1 China Sorafenib Sales and Value (2012-2017)
  7.1.1 China Sorafenib Sales and Growth Rate (2012-2017)
  7.1.2 China Sorafenib Revenue and Growth Rate (2012-2017)
  7.1.3 China Sorafenib Sales Price Trend (2012-2017)
7.2 China Sorafenib Sales and Market Share by Manufacturers
7.3 China Sorafenib Sales and Market Share by Type
7.4 China Sorafenib Sales and Market Share by Application

8 EUROPE SORAFENIB (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Sorafenib Sales and Value (2012-2017)
  8.1.1 Europe Sorafenib Sales and Growth Rate (2012-2017)
  8.1.2 Europe Sorafenib Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Sorafenib Sales Price Trend (2012-2017)
8.2 Europe Sorafenib Sales and Market Share by Manufacturers
8.3 Europe Sorafenib Sales and Market Share by Type
8.4 Europe Sorafenib Sales and Market Share by Application

9 JAPAN SORAFENIB (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Sorafenib Sales and Value (2012-2017)
  9.1.1 Japan Sorafenib Sales and Growth Rate (2012-2017)
  9.1.2 Japan Sorafenib Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Sorafenib Sales Price Trend (2012-2017)
9.2 Japan Sorafenib Sales and Market Share by Manufacturers
9.3 Japan Sorafenib Sales and Market Share by Type
9.4 Japan Sorafenib Sales and Market Share by Application

10 GLOBAL SORAFENIB MANUFACTURERS ANALYSIS

10.1 Pfizer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Allergan
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Alnylam Pharmaceuticals
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Amgen
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Angstrom Pharmaceuticals
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Acceleron Pharma
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Biocon
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Bionomics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 CASI Pharmaceuticals
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL SORAFENIB MARKET FORECAST (2017-2022)

13.1 Global Sorafenib Sales, Revenue Forecast (2017-2022)
13.2 Global Sorafenib Sales Forecast by Regions (2017-2022)
13.3 Global Sorafenib Sales Forecast by Type (2017-2022)
13.4 Global Sorafenib Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Sorafenib
Table Classification of Sorafenib
Figure Global Sales Market Share of Sorafenib by Type in 2016
Table Applications of Sorafenib
Figure Global Sales Market Share of Sorafenib by Application in 2016
Figure United States Sorafenib Revenue and Growth Rate (2012-2022)
Figure China Sorafenib Revenue and Growth Rate (2012-2022)
Figure Europe Sorafenib Revenue and Growth Rate (2012-2022)
Figure Japan Sorafenib Revenue and Growth Rate (2012-2022)
Figure Global Sorafenib Sales and Growth Rate (2012-2022)
Figure Global Sorafenib Revenue and Growth Rate (2012-2022)
Table Global Sorafenib Sales of Key Manufacturers (2012-2017)
Table Global Sorafenib Sales Share by Manufacturers (2012-2017)
Figure 2015 Sorafenib Sales Share by Manufacturers
Figure 2016 Sorafenib Sales Share by Manufacturers
Table Global Sorafenib Revenue by Manufacturers (2012-2017)
Table Global Sorafenib Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Sorafenib Revenue Share by Manufacturers
Table 2016 Global Sorafenib Revenue Share by Manufacturers
Table Global Sorafenib Sales and Market Share by Type (2012-2017)
Table Global Sorafenib Sales Share by Type (2012-2017)
Figure Sales Market Share of Sorafenib by Type (2012-2017)
Figure Global Sorafenib Sales Growth Rate by Type (2012-2017)
Table Global Sorafenib Revenue and Market Share by Type (2012-2017)
Table Global Sorafenib Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Sorafenib by Type (2012-2017)
Figure Global Sorafenib Revenue Growth Rate by Type (2012-2017)
Table Global Sorafenib Sales and Market Share by Regions (2012-2017)
Table Global Sorafenib Sales Share by Regions (2012-2017)
Figure Sales Market Share of Sorafenib by Regions (2012-2017)
Figure Global Sorafenib Sales Growth Rate by Regions (2012-2017)
Table Global Sorafenib Revenue and Market Share by Regions (2012-2017)
Table Global Sorafenib Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Sorafenib by Regions (2012-2017)
Figure Global Sorafenib Revenue Growth Rate by Regions (2012-2017)
Table Global Sorafenib Sales and Market Share by Application (2012-2017)
Table Global Sorafenib Sales Share by Application (2012-2017)
Figure Sales Market Share of Sorafenib by Application (2012-2017)
Figure Global Sorafenib Sales Growth Rate by Application (2012-2017)
Figure United States Sorafenib Sales and Growth Rate (2012-2017)
Figure United States Sorafenib Revenue and Growth Rate (2012-2017)
Figure United States Sorafenib Sales Price Trend (2012-2017)
Table United States Sorafenib Sales by Manufacturers (2012-2017)
Table United States Sorafenib Market Share by Manufacturers (2012-2017)
Table United States Sorafenib Sales by Type (2012-2017)
Table United States Sorafenib Market Share by Type (2012-2017)
Table United States Sorafenib Sales by Application (2012-2017)
Table United States Sorafenib Market Share by Application (2012-2017)
Figure China Sorafenib Sales and Growth Rate (2012-2017)
Figure China Sorafenib Revenue and Growth Rate (2012-2017)
Figure China Sorafenib Sales Price Trend (2012-2017)
Table China Sorafenib Sales by Manufacturers (2012-2017)
Table China Sorafenib Market Share by Manufacturers (2012-2017)
Table China Sorafenib Sales by Type (2012-2017)
Table China Sorafenib Market Share by Type (2012-2017)
Table China Sorafenib Sales by Application (2012-2017)
Table China Sorafenib Market Share by Application (2012-2017)
Figure Europe Sorafenib Sales and Growth Rate (2012-2017)
Figure Europe Sorafenib Revenue and Growth Rate (2012-2017)
Figure Europe Sorafenib Sales Price Trend (2012-2017)
Table Europe Sorafenib Sales by Manufacturers (2012-2017)
Table Europe Sorafenib Market Share by Manufacturers (2012-2017)
Table Europe Sorafenib Sales by Type (2012-2017)
Table Europe Sorafenib Market Share by Type (2012-2017)
Table Europe Sorafenib Sales by Application (2012-2017)
Table Europe Sorafenib Market Share by Application (2012-2017)
Figure Japan Sorafenib Sales and Growth Rate (2012-2017)
Figure Japan Sorafenib Revenue and Growth Rate (2012-2017)
Figure Japan Sorafenib Sales Price Trend (2012-2017)
Table Japan Sorafenib Sales by Manufacturers (2012-2017)
Table Japan Sorafenib Market Share by Manufacturers (2012-2017)
Table Japan Sorafenib Sales by Type (2012-2017)
Table Japan Sorafenib Market Share by Type (2012-2017)
Table Japan Sorafenib Sales by Application (2012-2017)
Table Japan Sorafenib Market Share by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Sorafenib Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Sorafenib Global Market Share (2012-2017)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alnylam Pharmaceuticals Sorafenib Global Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Sorafenib Global Market Share (2012-2017)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Angstrom Pharmaceuticals Sorafenib Global Market Share (2012-2017)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acceleron Pharma Sorafenib Global Market Share (2012-2017)
Table Biocon Basic Information List
Table Biocon Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biocon Sorafenib Global Market Share (2012-2017)
Table Bionomics Basic Information List
Table Bionomics Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bionomics Sorafenib Global Market Share (2012-2017)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CASI Pharmaceuticals Sorafenib Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sorafenib
Figure Manufacturing Process Analysis of Sorafenib
Figure Sorafenib Industrial Chain Analysis
Table Raw Materials Sources of Sorafenib Major Manufacturers in 2016
Table Major Buyers of Sorafenib
Table Distributors/Traders List
Figure Global Sorafenib Sales and Growth Rate Forecast (2017-2022)
Figure Global Sorafenib Revenue and Growth Rate Forecast (2017-2022)
Table Global Sorafenib Sales Forecast by Regions (2017-2022)
Table Global Sorafenib Sales Forecast by Type (2017-2022)
Table Global Sorafenib Sales Forecast by Application (2017-2022)

COMPANIES MENTIONED

Pfizer
Allergan
Alnylam Pharmaceuticals
Amgen
Angstrom Pharmaceuticals
Acceleron Pharma
Biocon
Bionomics
CASI Pharmaceuticals
Celgene Corporation
Enzon Pharmaceuticals
Five Prime Therapeutics
Fujifilm Kyowa Kirin Biologics
Genentech
Genexine
Hetero Drugs
ImClone Systems
Intas Pharmaceuticals
Kyowa Hakko Kirin
Levolta Pharmaceuticals
Mabtech
Marsala Biotech
Neumedicines
Novartis
Oncobiologics
Onyx Pharmaceuticals